The diagnostic algorithm for venous thromboembolism (VTE) currently involves a composite of pre-test probability, D-dimer and imaging. Other laboratory tests, however, may assist in the identification of patients with VTE. Aim To assess the accuracy of different coagulation tests (D-dimer, thrombin generation, phospholipiddependent (PPL) clotting time, soluble P-selectin (sPselectin)) as biomarkers of acute VTE. Methods Random samples arriving at the Coagulation Laboratory at Mater Dei Hospital (Msida, Malta) from the Accident and Emergency Department with a request for D-dimer measurement were collected between August 2015 and February 2016. The following tests were performed: Innovance D-dimer (Siemens Healthcare Diagnostics), HemosIL D-dimer HS (Instrumentation Laboratory), thrombin generation (using the calibrated automated thrombogram), STA Procoag PPL (Diagnostica Stago) and sP-selectin (Affymetrix; eBioscience). VTE was objectively confirmed by compression ultrasonography, CT pulmonary angiography or ventilation/perfusion lung scan. results 100 samples were collected (33 with VTE). A strong positive linear correlation was found between the two D-dimer tests (r=0.97, p<0.001). Patients with VTE showed significantly higher sP-selectin concentrations compared with patients without VTE (75.7 ng/mL vs 53.0 ng/mL, p<0.001). In the random forest plot, the two D-dimer assays showed the highest variable importance, followed by sP-selectin. A sP-selectin cut-off of 74.8 ng/ mL was associated with 72.7% sensitivity and 78.2% specificity for acute VTE in our cohort. Conclusion Our results confirmed D-dimer as the main biomarker of VTE and speculated a role for sPselectin. The impact of thrombin generation was limited and no role emerged for the PPL clotting time. These observations need to be confirmed in large management studies.
Biomarkers for the diagnosis of venous thromboembolism: D-dimer, thrombin generation, procoagulant phospholipid and soluble P-selectin
InTrOduCTIOn
Venous thromboembolism (VTE), which encompasses deep vein thrombosis (DVT) and pulmonary embolism (PE), is a common public health problem worldwide, with an incidence of approximately 100 new cases per 100 000 persons every year. 1 The diagnostic algorithm for VTE currently involves a composite of clinical pre-test probability scores (such as the Wells or the Geneva scores [2] [3] [4] ), laboratory D-dimer and specific imaging tests (such as compression ultrasound for DVT and CT or ventilation/perfusion lung scan for PE).
D-dimer is a very useful diagnostic test to rule out the suspicion of VTE, due to its high sensitivity and negative predictive value. 5 However, the low specificity mandates further diagnostic tests to confirm the diagnosis of VTE. Furthermore, there are other laboratory coagulation tests (such as thrombin generation, procoagulant phospholipid-dependent clotting time and soluble P-selectin (sP-selectin)) that are currently used only for research purposes but might contribute to identify a prothrombotic predisposition. So far, some alterations of the thrombin generation parameters have been reported in patients with VTE, although at a small extent. [6] [7] [8] Studies evaluating patients with acute DVT showed increased values of sP-selectin compared with normal controls. 9 10 Finally, the procoagulant phospholipid-dependent clotting time can detect the presence of procoagulant microparticles in the plasma, 11 but has never been tested in the diagnosis of VTE before.
The aim of this study was to evaluate the accuracy of different laboratory tests (D-dimer, thrombin generation, phospholipid-dependent clotting time and sP-selectin), and their relative importance, as biomarkers of acute VTE.
MATerIAls And MeThOds study population
From August 2015 to February 2016, we collected random samples arriving at the Coagulation Laboratory at Mater Dei Hospital (in Msida, Malta) from the Accident and Emergency Department with a request for D-dimer measurement. This sample collection was part of a service development initiative due to the imminent change in the D-dimer assay in our laboratory and the need to test a certain number of samples with both assays in order to assure reproducible results. Samples were divided into three groups: negative D-dimer without VTE (group 1), positive D-dimer without VTE (group 2) and samples from patients with VTE confirmed by compression ultrasonography, CT pulmonary angiography or ventilation/perfusion lung scan (group 3). We planned a sample size of at least 25 patients per group. All samples were taken before any anticoagulants were administered and before a diagnostic test was performed. The decision whether to perform imaging tests was entirely left at the discretion of the attending physicians; however, none of 
statistical analysis
Continuous variables were expressed as mean±SD or as median with IQR, when data did not have a normal distribution (according to the Wilk-Shapiro test); categorical variables were expressed as counts and percentages. Continuous variables were compared using the Mann-Whitney U test for the comparison of two groups or the Kruskal-Wallis test for the comparison of three or more groups (the Dunn's test with p values adjusted with the Bonferroni correction was used for the post hoc analysis). Unadjusted and adjusted median differences (according to age and sex), together with their 95% CI, were also calculated.
Significant results were graphically represented using box-andwhisker plots, where the line inside the box is the median value, and the bottom and top limits of the box represent the first and third quartiles. The whiskers represent the lower and the upper adjacent values, while the outliers are represented as dots.
The correlation between different laboratory tests was evaluated using non-parametric Spearman's rank correlation test, according to data distribution, and the correlation coefficients (r) were calculated. In order to evaluate the clinical agreement and to estimate the percentage of D-dimer values that might have resulted in a different clinical management, the D-dimer values were categorised as positive or negative, according to the manufacturers' cut-offs (500 ng/mL fibrinogen equivalent units (FEU) for the Innovance D-dimer and 230 ng/mL for the HemosIL D-dimer).
To assess the predictive accuracy of each biomarker, we measured the area under the receiver operating characteristic (ROC) curves, equivalent to the c (concordance)-statistics. The c-statistic represents the concordance between predicted and observed events, with c=0.5 for prediction no better than chance and c=1.0 for perfect discriminative ability. 12 Considering only those samples with all test results available, we applied random forest algorithm to identify the relative importance of each biomarker in VTE prediction (Innovance D-dimer, HemosIL D-dimer, lag time, peak thrombin concentration, time to peak, endogenous thrombin potential, velocity index, phospholipid-dependent clotting time and sP-selectin).
In this procedure, 1000 decision trees were grown to form the random forest and a random subset of variable was used at each split point with three out of nine variables used in each subset. The out-of-bag error was calculated as an unbiased estimate of misclassification error of the random forest method. The random forest method was applied to two different models:
(1) considering all potential biomarkers of VTE; (2) excluding D-dimers, which are well-known biomarkers of VTE, in order to identify any other emergent biomarker which might be obscured by the D-dimers. To assess the importance of the variables, we evaluated mean minimal depth (it assumes that variables with high impact on the prediction are those that most frequently split nodes nearest the root of the trees), accuracy decrease (mean decrease of prediction accuracy) and Gini decrease (mean decrease in the Gini index of node impurity). A decisional classification tree algorithm was applied to biomarkers identified by the random forest, to find the cut-offs associated with the highest sensitivity/specificity.
Data analysis was performed using the statistical software STATA SE V.12 (StataCorp LP, College Station, Texas, USA), SAS V.9.4 (SAS Institute, Cary, North Carolina, USA) and R software packages (Party and randomForest). [13] [14] [15] Two-tailed p values less than 0.05 were considered statistically significant.
resulTs study population
Overall, 100 samples were collected. Median (IQR) age was 59.0 (41.3-70.2) years, and 47% were men. Thirty-three patients had confirmed VTE: 16 PE, 11 lower limb proximal DVT and three isolated distal DVT, one upper limb proximal DVT and two superficial vein thrombosis of the great saphenous vein. Patients with VTE were significantly older than patients without VTE (median age 69.5 vs 52.0, respectively, p<0.001), while sex distribution was not significantly different (men 45.5% vs 47.8%, respectively, p=0.83).
d-dimers
A strong positive linear correlation was found between the two D-dimers (r=0.97, p<0.001) and is shown in figure 1 . The clinical agreement between the two D-dimers in the categorisation of patients as positive/negative was 93.8% since four patients with positive Innovance D-dimer were classified as negative by HemosIL D-dimer HS and one patient with positive HemosIL D-dimer HS was classified as negative by Innovance D-dimer. None of these five patients had VTE and overall none of the patients with VTE had a negative D-dimer.
Thrombin generation
On the thrombin generation curve, patients with VTE showed prolonged lag time (median 5.42 vs 4.5 min, p<0.001) and prolonged time to peak (median 8.59 vs 7.33 min, p=0.004) compared with patients without VTE. After adjustment for age and sex, median lag time, time to peak and also velocity index were significantly different between the two groups. Detailed results are reported in table 1 and figure 2 .
Results of thrombin generation divided into the three groups of patients are reported in table 2. Apart from the differences between patients with and without VTE, among patients without VTE, we observed that those with positive D-dimer had higher peak thrombin concentration (median 318.2 vs 278.5 nM, p=0.007) and higher velocity index (median 121.2 vs 91.6 nM/min, p=0.003) compared with those with negative D-dimer. 
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Table 2 Results of thrombin generation, procoagulant phospholipid-dependent clotting time and soluble P-selectin in the three subgroups of patients: negative D-dimer without VTE (group 1), positive D-dimer without VTE (group 2) and patients with VTE (group 3)
Procoagulant phospholipid-dependent clotting time
There was no difference in the phospholipid-dependent clotting time between patients with and without VTE (table 1) , or between patients with positive versus negative D-dimer (table 2) . These results did not change when the phospholipid-dependent clotting time was expressed as ratio (tables 1-2).
soluble P-selectin
The median concentration of sP-selectin was significantly higher in patients with VTE compared with patients without VTE (75.7 ng/mL vs 53.0 ng/mL, p<0.001; adjusted median difference 25.1, 95% CI 11.7 to 38.5) (table 1, figure 2) . No difference was found between patients with positive versus negative D-dimer (table 2) . 
Correlation between d-dimers and the other biomarkers of VTe

receiver operating characteristic curves
Excluding the D-dimers, which are well-known biomarkers of VTE and which may have been influenced by our sample selection, among the other potential biomarkers the best predictive value for VTE was identified by the sP-selectin concentration 
Importance of each biomarker in VTe prediction
A random forest plot, generated from data of 69 patients with all test results, showed that the two D-dimer assays had the highest variable importance, followed by sP-selectin concentration, with an out-of-bag error (prediction error of the random forests algorithm) of 10% ( figure 4A,B ). In the model without D-dimers, sP-selectin concentration was the most relevant biomarker ( figure 4C,D) . The classification tree on sP-selectin showed that the best cut-off in our sample was 74.8 ng/ mL with a sensitivity of 72.7% and a specificity of 78.2%.
In order to evaluate whether the sP-selectin might improve the predictive ability of the D-dimers, we created two logistic models considering these biomarkers as dichotomous variables (Innovance D-dimer and HemosIL D-dimer HS according to manufacturers' cut-off, sP-selectin positive above our identified cut-off of 74.8 ng/mL). We observed that the addition of sP-selectin improved both the AUC of the HemosIL D-dimer HS (p=0.0004) and the AUC of the Innovance D-dimer (p=0.0006).
dIsCussIOn
In this study, we evaluated several tests, namely two D-dimers, the thrombin generation, the phospholipid-dependent clotting time and the sP-selectin, as potential biomarkers of VTE. Our results suggest that the sP-selectin concentration has a good 
Original article Figure 4 Random forest and multiway importance plot for the model including all potential biomarkers of venous thromboembolism (A, B) and for the model excluding the D-dimers (C, D).
In the random forest method,1000 decision trees were grown to form the random forest. A random subset of variable was used at each split point (three random variables out of nine available were used in each subset). Only variables that were chosen at least in half of the trees are represented. Minimal depth is the distance from the root of the tree and assumes that variables with high impact on the prediction most frequently split nodes near the root of the trees. Accuracy decrease is the mean decrease of prediction accuracy when a certain variable is removed from the model. Gini index decrease is the mean decrease in the index of node impurity (eg, the variance in a node). The higher decrease of accuracy and Gini index means higher variable importance. ETP, endogenous thrombin potential; TG, thrombin generation.
predictive value for the diagnosis of VTE and can also improve the predictive ability of the D-dimer tests.
D-dimers are well-known biomarkers of VTE with small differences in sensitivity and specificity reported with the use of different assays. 16 The Innovance D-dimer and the HemosIL D-dimer HS are two latex-enhanced turbidimetric immunoassays, and are classified among those with the highest sensitivity for VTE (93%-95%), although at the price of lower specificity (50%-53%). 5 We found a strong positive linear correlation between these two D-dimers (r=0.97) and a very good clinical agreement, with 93.8% of samples equally classified as negative or positive. Despite the design of our study not allowing calculation of specificity and sensitivity, we observed less false-positive results with the HemosIL D-dimer HS, in line with the very high negative predictive value reported by the manufacturer.
In our study, two thrombin generation parameters emerged as potentially associated with the diagnosis of VTE: prolonged lag time and time to peak. Although in hypercoagulable states the lag time (time until the initiation of thrombin generation) and the time to peak (time to reach the peak thrombin concentration) are usually shortened, 17 several previous studies analysing patients with suspected VTE reported prolonged lag time and time to peak in those with confirmed VTE. 6-8 18 These findings suggested that the thrombin generation on the CAT is delayed and prolonged in patients with acute VTE and, therefore, several authors have hypothesised that the increased thrombin generation in vivo is associated with consumption of coagulation factors and reduced thrombin generation potential ex vivo. 7 8 In contrast, the endogenous thrombin potential (the total amount of thrombin generated), which is considered to be the parameter that best reflects the actual generation of thrombin, has been reported to be increased in acute VTE in some studies, 6 7 while in others, 8 18 including our study, no statistically significant difference emerged between the two groups. However, the diagnostic accuracy and the relevance of the thrombin generation parameters in our study cohort was inferior compared with other biomarkers, suggesting a limited application of this test to VTE diagnosis.
Our study, for the first time, evaluated the phospholipid-dependent clotting time in the setting of VTE diagnosis. The phospholipid-dependent coagulation time is a functional test that measures a clotting time dependent on procoagulant phospholipid and is based on the principle that procoagulant microparticles will shorten the activated factor X clotting time. 11 19 Microparticles are emerging biomarkers of venous thrombosis, being increased in patients with acute VTE, although it is still unclear whether microparticles themselves are a cause or a consequence of the thrombosis. 20 Microparticles are traditionally measured by flow cytometry, which provides information about their absolute number and cellular origin, but cannot detect their functional activity. 19 Considering the great correlation between the phospholipid-dependent clotting time and flow cytometry, 11 19 we hypothesised that the phospholipid-dependent clotting time could be useful also in the management of patients with suspected VTE. However, our results showed that this assay does not appear to be correlated with the diagnosis of VTE.
Finally, we investigated P-selectin, a cell adhesion molecule, expressed on the surface of activated platelets and endothelial cells, which can be released in soluble form into the plasma. 21 Recent evidence suggest that P-selectin might have a role also in thrombosis and haemostasis since it can mediate platelet rolling, generate procoagulant microparticles and enhance fibrin deposition. 22 23 In our study, sP-selectin showed a good predictive value and was the most relevant biomarker of VTE, after the D-dimers. Furthermore, we identified a sP-selectin cut-off of 74.8 ng/ mL, which showed high sensitivity (72.7%) and high specificity (78.2%) in our cohort.
Our results are in line with previous findings. Rectenwald et al, 9 in a pilot study of patients diagnosed with DVT, reported higher mean concentrations of sP-selectin in 22 patients with acute DVT (0.98±2.03 ng/mg of total protein) compared with 21 symptomatic patients without DVT (0.55±0.08) and 30 controls (0.34±0.05). They also identified a threshold of sP-selectin (0.68 ng/mg of total protein), which provided the highest sensitivity and the highest specificity (68% and 81%, respectively). Furthermore, combining this threshold of sP-selectin with total microparticles (>125% of controls) and D-dimer (>3 mg/L), they obtained a sensitivity of 73% and a specificity of 81%. 9 Ramacciotti et al 10 reported higher levels of sP-selectin in 62 patients with DVT versus 116 patients without DVT (87.3±44 ng/L vs 53.4±24 ng/mL, p<0.0001). A combination of sP-selectin cut-off ≥90 ng/mL combined with Wells score ≥2 resulted in a specificity of 95%, a sensitivity of 33% and a positive predictive value of 100% for the diagnosis of DVT. In contrast, a combination of sP-selectin cut-off ≤60 ng/mL combined with Wells score <2 resulted in a sensitivity of 99%, a specificity of 33% and a negative predictive value of 96% for the exclusion of DVT. 10 More recently, Torres et al 24 reported a trend towards increased value of sP-selectin in 15 patients with previous VTE versus 20 normal individuals (median concentration 90 vs 72 ng/mL, respectively, p=0.099). However, in this study, blood samples were collected after the acute phase (at least a month after the last VTE).
The main strength of our study is the simultaneous comparison of different biomarkers in suspected VTE with objectively confirmed VTE at imaging tests. However, there are also some limitations that need to be acknowledged. First, not all test results were available for all samples, due to technical errors in the tests or insufficient plasma available. Furthermore, being a collection of anonymised samples, sex and age were the only available demographic characteristics and we could not apply a posteriori the clinical prediction rules for VTE. Second, the median time to storage of VTE samples was longer than the other patient groups (approximately 4.5 vs 1.5 hours). While there is some evidence that changes in D-dimer are low after storage at room temperature for up to 24 hours, 25 26 data regarding plasma stability for the other tests are scarce. However, our results are in line with previous studies addressing the role of thrombin generation, on samples stored within 1-2 hours from collection, which reported a prolongation of lag time and time to peak in patients with VTE. 7 8 On the other hand, it is unknown whether the delayed freezing time could have influenced the phospholipid-dependent clotting time or the sP-selectin concentration. Third, our sample size was relatively small, but similar to previous studies assessing the role of sP-selectin in patients with suspected VTE. 9 24 In conclusion, our study confirmed the D-dimer as the main biomarker of VTE and hypothesised a role for sP-selectin. The impact of thrombin generation is limited, while it seems that there is no role for phospholipid-dependent clotting time. However, these data should be confirmed in large management studies.
Take home messages
► The Innovance D-dimer and the HemosIL D-dimer HS showed a strong positive linear correlation. ► The two D-dimer assays showed the highest variable importance, in patients with suspected venous thromboembolism, followed by soluble P-selectin (sP-selectin) concentrations ► A sP-selectin cut-off of 74.8 ng/mL was associated with 72.7% sensitivity and 78.2% specificity for acute venous thromboembolism. ► Thrombin generation had a limited impact as biomarker of venous thromboembolism, while no role emerged for the phospholipid-dependent clotting time.
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